24.09.2015
- Denmark’s Novo Nordisk has announced plans to build a new €70 million plant to manufacture insulin pens in Iran, becoming the first Western drugmaker to announce investment plans...
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
02.06.2014
- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
15.08.2013
- China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the...
12.08.2013
- China has started investigating French drugmaker Sanofi for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China...
09.08.2013
- Chinese authorities have visited a site operated by Danish drug maker Novo Nordisk, the world's biggest maker of insulin, in the latest sign of a widening investigation into...
18.07.2013
- Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...
